Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Intercure (NASDAQ:INCR) through any online brokerage.
Other companies in Intercure’s space includes: Cingulate Inc (NASDAQ:CING), Cumberland Pharmaceuticals Inc (NASDAQ:CPIX), Universe Pharmaceuticals Inc (NASDAQ:UPC), Lipocine Inc (NASDAQ:LPCN) and Nutriband Inc (NASDAQ:NTRB).
Intercure has a consensus price target of $5.00.
The stock price for Intercure (NASDAQ: INCR) is $0.98 last updated January 14, 2026 at 9:07 AM EST.
There are no upcoming dividends for Intercure.
Intercure does not have any upcoming earnings scheduled.
There is no upcoming split for Intercure.
Intercure is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.